| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965920 | Vaccine | 2014 | 8 Pages |
Abstract
The prioritization of trial-related financial and healthcare provisions, including access to an efficacious vaccine posttrial, among MSM in India indicates the importance of trials providing such services, as well as the value of formative research in identifying key concerns among participating communities in resource-limited settings. The significant impact of trial characteristics on WTP suggests that providing trial benefits deemed fair and important, addressing logistical concerns, and supporting educational interventions to mitigate vaccine fears may support recruitment of MSM in India in fairly and ethically conducted HIV vaccine trials.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Peter A. Newman, Venkatesan Chakrapani, James Weaver, Murali Shunmugam, Clara Rubincam,